TheScreener - Procter Gamble Hygiene Health Care Lt (PGHH) PG.HYGIENE HCRE.LTD. reduced its risk exposure resulting in an upgrade to Slightly Positive

Report

TheScreener

EUR 13.66 For Business Accounts Only

P&G.HYGIENE & HCRE.LTD. reduced its risk exposure resulting in an upgrade to Slightly Positive

P&G.HYGIENE & HCRE.LTD. (IN), a company active in the Personal Products & Services industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date February 25, 2020, the closing price was INR 11,177.30 and its potential was estimated at INR 12,626.79.

26/02/2020 6 EN

Underlying

Procter & Gamble Hygiene & Health Care Lt

Procter & Gamble Hygiene and Health Care Limited is an India-based company, which is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. The Company offers ayurvedic products and sanitary napkins. The Company is involved in manufacturing, trading and marketing of health and hygiene products. The Company's brands include Ambi Pur, Ariel, Duracell, Gillette, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide, Vicks, Wella and Whisper. The Company's products include ointments and creams, cough drops, tablets, personal products and toilet preparations, among others. The Company's products are sold through retail operations, including mass merchandisers, grocery stores, membership club stores, drug stores, department stores and high frequency stores. The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, apart from third-party manufacturing locations spread across India.

See profile

INE179A01014 National Stock Exchange of India India

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

Motilal Oswal

MOSL : P&G HYGIENE AND HEALTHCARE: Commodity pressures hurt margins

. P&G HYGIENE AND HEALTHCARE: Commodity pressures hurt margins (PG IN, Mkt Cap USD5.8b, CMP INR14393, TP INR16500, 15% Upside, Buy) While the sales decline of 3.7% YoY in 4QFY22 (adjusted for a one-off in other operating income) was optically poor, it was on an unusually high base of Vicks sales in FY21 (24.1%) that may have been especially strong in 4QFY21 given the second wave of Covid-19. Even so, the two-year sales CAGR, which has been in the 12-17% range in the preceding three quarters, stood at only 9.2% in 4QFY22. As a percentage of sales, PGHH's ad spends declined sharply by 1,19...

EUR 120.00

August 24, 2022 August 24, 2022 8 EN

Motilal Oswal

MOSL: P&G HYGIENE AND HEALTHCARE (Buy) – ANNUAL REPORT UPDATE: Strong broad-based topline growth

P&G HYGIENE AND HEALTHCARE – ANNUAL REPORT UPDATE: Strong broad-based topline growth; ad spends to stabilize at lower levels (PG IN, Mkt Cap USD6.3b, CMP INR14371, TP INR17450, 21% Upside, Buy) Here are the key takeaways from P&G Hygiene and Healthcare (PGHH)’s FY21 Annual Report: Feminine Hygiene and Healthcare segments report strong growth: PGHH continued to strengthen its brand fundamentals with innovation, product launches, distribution expansion, and superior communication and execution. Sales grew 19.1% YoY in FY21, led by the Feminine Hygiene (66% of sales; up 16.7% YoY) and Hea...

EUR 120.00

November 9, 2021 November 9, 2021 22 EN

Motilal Oswal

MOSL: P&G HYGIENE AND HEALTHCARE (Buy)-Sales disappoint; margin surprise lead to profit beat

P&G HYGIENE AND HEALTHCARE: Sales disappoint; margin surprise lead to profit beat (PG IN, Mkt Cap USD6.2b, CMP INR14302, TP INR17450, 22% Upside, Buy) PGHH's sales growth of ~5% was lower than our expectation, albeit on a base of 18.5% growth. While the company does not share segment-wise numbers in its interim results, it is likely that high Healthcare segment sales growth in the base quarter may have led to modest sales growth in 1QFY22 (June year-end company). The Healthcare segment had grown by ~24% in FY21, partly aided by the COVID-19 wave, leading to strong sales growth for all H...

EUR 120.00

November 3, 2021 November 3, 2021 10 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

P&G.HYGIENE & HCRE.LTD. reduced its risk exposure resulting in an upgrade to Slightly Positive

Empowering Investors

MOSL : P&G HYGIENE AND HEALTHCARE: Commodity pressures hurt margins

MOSL: P&G HYGIENE AND HEALTHCARE (Buy) – ANNUAL REPORT UPDATE: Strong broad-based topline growth

MOSL: P&G HYGIENE AND HEALTHCARE (Buy)-Sales disappoint; margin surprise lead to profit beat

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe